levodopa has been researched along with Developmental Psychomotor Disorders in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, C; Dimov, A; Kopell, BH; Panov, FE; Ramdhani, R; Rasouli, J; Wang, Y; Zhang, Y | 1 |
| Augustine, GJ; Cho, KH; Cho, SH; Chung, JH; Jeong, M; Jeong, Y; Jo, S; Kim, D; Kim, J; Kim, Y; Nakajima, R; Paik, SB; Park, AH; Park, H; Shim, I; Shin, A; Yang, S | 1 |
| Gelfius, CD; Mortimer, D; Potts, MA | 1 |
| Friedman, JR | 1 |
| Chigir', IP; Dokadina, LV; Fedorova, NV; Levin, OS; Makhnev, SO; Smolentseva, IG | 1 |
| Blau, N; Jakobs, C; Jansen, EE; Kusmierska, K; Malunowicz, E; Meilei, D; Pronicka, E; Rokicki, D; Sykut-Cegielska, J; Szymanska, K; Thony, B; Tryfon, J | 1 |
| Bakheit, AM; Brennan, A; Fletcher, K | 1 |
| Eidelberg, D; Feigin, A; Niethammer, M | 1 |
| Blau, N; Hoffmann, GF; Kühn, AA; Opladen, T | 1 |
| Ardouin, C; Benabid, AL; Fraix, V; Funkiewiez, A; Krack, P; Moro, E; Pollak, P; Van Blercom, N; Xie, J | 1 |
| Clarke, CE; Counsell, C; Gray, R; Ives, NJ; Macleod, A; Marro, J; Stowe, RL; Wheatley, K | 1 |
| Al Hassan, K; Lang, AE; Miyasaki, JM; Voon, V | 1 |
| Martí-Massó, JF | 1 |
| De Weerdt, W; Dom, R; Lesaffre, E; Nieuwboer, A | 1 |
| Avraham, M; Dabby, R; Djaldetti, R; Melamed, E; Ziv, I; Zoldan, J | 1 |
| Azulay, JP; Blin, O; Darmon, A; Pouget, J | 1 |
| Bennett, G; Walsh, K | 1 |
| Filion, M; Langelier, P; Larochelle, L; Poirier, L | 1 |
| Montastruc, JL; Rascol, A; Rascol, O | 1 |
| Benabid, AL; Champay, AS; Gaio, JM; Hommel, M; Perret, J; Pollak, P | 1 |
| Fischer, PA; Jacobi, P; Maxion, H; Schneider, E | 1 |
10 review(s) available for levodopa and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Functional neuroimaging in Parkinson's disease.
Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Levodopa: management of Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Levodopa; Parkinson Disease; Psychomotor Disorders; Psychomotor Performance; Randomized Controlled Trials as Topic | 2002 |
DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Topics: Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Psychomotor Disorders; Randomized Controlled Trials as Topic | 2002 |
DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Topics: Apomorphine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Psychomotor Disorders; Randomized Controlled Trials as Topic | 2002 |
DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Topics: Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Psychomotor Disorders; Randomized Controlled Trials as Topic; Thiazoles | 2002 |
Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients.
Topics: Antiparkinson Agents; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Psychomotor Disorders; Randomized Controlled Trials as Topic | 2004 |
[Drug-related motor disorders in aged people].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aging; Antiparkinson Agents; Antipsychotic Agents; Calcium Channel Blockers; Humans; Levodopa; Psychomotor Disorders | 1997 |
[Posture and gait modulation using sensory or attentional cues in Parkinson's disease. A possible approach to the mechanism of episodic freezing].
Topics: Adaptation, Physiological; Aged; Antiparkinson Agents; Attention; Cognitive Behavioral Therapy; Cues; Gait; Humans; Levodopa; Parkinson Disease; Posture; Psychomotor Disorders | 1999 |
Parkinson's disease and anxiety.
Topics: Aged; Anti-Anxiety Agents; Antiparkinson Agents; Anxiety Disorders; Humans; Levodopa; Parkinson Disease; Prevalence; Psychomotor Disorders | 2001 |
Brain nervous mechanisms involved in the so-called extra pyramidal motor and psychomotor disturbances.
Topics: Animals; Athetosis; Basal Ganglia Diseases; Brain; Brain Stem; Cats; Corpus Striatum; Disease Models, Animal; Dopa Decarboxylase; Dopamine; Extrapyramidal Tracts; Globus Pallidus; Haplorhini; Homovanillic Acid; Humans; Levodopa; Monoamine Oxidase; Neural Pathways; Olivary Nucleus; Psychomotor Disorders; Red Nucleus; Tyrosine 3-Monooxygenase | 1975 |
3 trial(s) available for levodopa and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
[The clinical-pharmacoeconomic study of efficacy of stalevo in the treatment of Parkinson's disease with motor fluctuations].
Topics: Antiparkinson Agents; Carbidopa; Catechols; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Disorders; Severity of Illness Index | 2008 |
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic | 1990 |
Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.
Topics: Aged; Amides; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior; Clinical Trials as Topic; Depression; Dopa Decarboxylase; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levodopa; Male; Melanocyte-Stimulating Hormones; Middle Aged; Oligopeptides; Parkinson Disease; Pituitary Hormone-Releasing Hormones; Placebos; Psychomotor Disorders; Sleep Wake Disorders | 1974 |
12 other study(ies) available for levodopa and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery.
Topics: Aged; Antiparkinson Agents; Brain Mapping; Deep Brain Stimulation; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Middle Aged; Neurologic Examination; Parkinson Disease; Postoperative Care; Psychomotor Disorders; Subthalamic Nucleus; Treatment Outcome | 2018 |
Inhibitory Basal Ganglia Inputs Induce Excitatory Motor Signals in the Thalamus.
Topics: Action Potentials; Alcohol Oxidoreductases; Animals; Calcium Channels, T-Type; Dopamine; Dystonia; Female; Globus Pallidus; Levodopa; Male; Metabolism, Inborn Errors; Mice; Mice, Knockout; Motor Neurons; Muscle Contraction; Neural Inhibition; Neural Pathways; Neurons; Psychomotor Disorders; Thalamus | 2017 |
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Psychomotor Disorders | 2013 |
What Is Not in the Name? Dopa-Responsive Dystonia May Respond to More Than L-Dopa.
Topics: 5-Hydroxytryptophan; Adolescent; Anti-Dyskinesia Agents; Carbidopa; Diseases in Twins; Dopamine Agonists; Drug Combinations; Dystonia; Female; Humans; Levodopa; Male; Metabolism, Inborn Errors; Psychomotor Disorders; Serotonin Agents | 2016 |
Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up.
Topics: 5-Hydroxytryptophan; Alcohol Oxidoreductases; Biogenic Amines; Child, Preschool; Dystonia; Female; Follow-Up Studies; Homozygote; Humans; Levodopa; Metabolism, Inborn Errors; Mutation, Missense; Psychomotor Disorders | 2009 |
Successful treatment of severe abulia with co-beneldopa.
Topics: Benserazide; Cranial Fossa, Posterior; Dopamine Agents; Drug Combinations; Female; Humans; Hydrocephalus; Levodopa; Meningeal Neoplasms; Meningioma; Middle Aged; Psychomotor Disorders; Speech Disorders | 2011 |
Pitfalls in phenylalanine loading test in the diagnosis of dopa-responsive dystonia.
Topics: Administration, Oral; Adult; Biopterins; Diagnosis, Differential; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Metabolism, Inborn Errors; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Psychomotor Disorders; Tyrosine | 2013 |
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Electric Stimulation Therapy; Female; Frontal Lobe; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychological Tests; Psychomotor Disorders; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time | 2003 |
Punding prevalence in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Parkinson Disease; Prevalence; Psychomotor Disorders | 2007 |
A frequency and correlation analysis of motor deficits in Parkinson patients.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Drug Therapy, Combination; Female; Humans; Incidence; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Prognosis; Psychomotor Disorders; Psychomotor Performance; Selegiline; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; Time Factors | 1998 |
Early-occurrence of manual motor blocks in Parkinson's disease: a quantitative assessment.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Psychomotor Disorders; Treatment Outcome | 1999 |
[Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease].
Topics: Adult; Aged; Apomorphine; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Disorders | 1990 |